Leonel García Benavides

Dr. Leonel García Benavides

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2002 in Journal of Hepatology
Verified
Journal Article
Closed access
LBLeonel García Benavides
Leonel García Benavides
IHIvan Hernández
Ivan Hernández
ASAna Sandoval-Rodriguez
Ana Sandoval-Rodriguez
ASAdriana Salazar
Adriana Salazar
JGJesus Garcia
Jesus Garcia
JAJuan Armendariz-Borunda
Juan Armendariz-Borunda

17 October 2006 in Gut
Verified
Journal Article
Closed access
PDF file
JAJuan Armendariz-Borunda
Juan Armendariz-Borunda
MIM C Islas-Carbajal
M C Islas-Carbajal
EME Meza-García
E Meza-García
ARA R Rincón
A R Rincón
SLS Lucano
S Lucano
LBLeonel García Benavides
Leonel García Benavides
PFD is an orally bioavailable pyridone derivative (5-methyl-1-phenyl-2-(1H)-pyridone) that affects a variety of profibrogenic cytokines and its mechanism of action mostly resides in its anti-inflammatory and antifibrotic activity.4– , 6 Here we present data obtained from a pilot clinical trial evaluating the safety and efficacy of PFD in 15 patients with established advanced liver disease caused by hepatitis C virus chronic infection. This is the first report showing improvements in liver histology (that is, necrosis, inflammation, steatosis, fibrosis, and cell regeneration) 12 months after PFD therapy. Colour Doppler ultrasound guided liver biopsies were obtained at baseline and after 12 months of PFD treatment and evaluated for stage of fibrosis and grade of activity according to the modified …

22 March 2016 in Hypertension in Pregnancy
Verified
Journal Article
Closed access
PDF file
EPE. E. Camarena Pulido
E. E. Camarena Pulido
LBLeonel García Benavides
Leonel García Benavides
JBJ. G. Panduro Barón
J. G. Panduro Barón
SGS. Pascoe Gonzalez
S. Pascoe Gonzalez
ASA. J. Madrigal Saray
A. J. Madrigal Saray
SSS. E. Totsuka Sutto
S. E. Totsuka Sutto
Objective: This study aimed to estimate the effectiveness of L-arginine for preventing preeclampsia in high-risk pregnancy. Methods: We performed a randomized, double-blind, placebo-controlled, clinical trial in patients with high-risk factors for preeclampsia. Fifty subjects received L-arginine, beginning from the 20th week of gestation. An additional 50 patients received homologated placebo. Results: The placebo group had a higher number of cases of preeclampsia (11/47) compared with the L-arginine group (3/49, P = 0.01). Birth weight was higher in the L-arginine group and there was a smaller number of preterm births (P = 0.03). Conclusion: L-arginine is effective for preventing preeclampsia.

1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
WTWalter Ángel Trujillo-Rangel
Walter Ángel Trujillo-Rangel
LGLeonel García-Valdés
Leonel García-Valdés
Miriam Méndez del VillarMiriam Méndez del Villar
Miriam Méndez del Villar
RCRolando Castañeda
Rolando Castañeda
STSylvia Elena Totsuka
Sylvia Elena Totsuka
LBLeonel García Benavides
Leonel García Benavides
Ischemia‐reperfusion (I‐R) injury is damage caused by restoring blood flow into ischemic tissues or organs. This complex and characteristic lesion accelerates cell death induced by signaling pathways such as apoptosis, necrosis, and even ferroptosis. In addition to the direct association between I‐R and the release of reactive oxygen species and reactive nitrogen species, it is involved in developing mitochondrial oxidative damage. Thus, its mechanism plays a critical role via reactive species scavenging, calcium overload modulation, electron transport chain blocking, mitochondrial permeability transition pore activation, or noncoding RNA transcription. Other receptors and molecules reduce tissue and organ damage caused by this pathology and other related diseases. These molecular targets have been gradually discovered and have essential roles in I‐R resolution. Therefore, the current study is aimed at highlighting the importance of these discoveries. In this review, we inquire about the oxidative damage receptors that are relevant to reducing the damage induced by oxidative stress associated with I‐R. Several complications on surgical techniques and pathology interventions do not mitigate the damage caused by I‐R. Nevertheless, these therapies developed using alternative targets could work as coadjuvants in tissue transplants or I‐R‐related pathologies

9 May 2017 in Journal of Investigative Surgery
Verified
Journal Article
Closed access
GRGuillermo Ramos-Gallardo
Guillermo Ramos-Gallardo
DODavid Orozco-Rentería
David Orozco-Rentería
PMPablo Medina-Zamora
Pablo Medina-Zamora
EMEduardo Mota-Fonseca
Eduardo Mota-Fonseca
LBLeonel García Benavides
Leonel García Benavides
JCJesus Aaron Curiel-Beltran
Jesus Aaron Curiel-Beltran
Introduction: Liposuction is a popular surgical procedure. As in any surgery, there are risks and complications, especially when combined with fat injection. Case reports of fat embolism have described a possible explanation as the puncture and tear of gluteal vessels during the procedure, especially when a deep injection is planned. Methods: A total of 10 dissections were performed in five fresh cadavers. Each buttocks was divided into four quadrants. We focused on the location where the gluteal vessels enter the muscle and the diameter of the vessels. Colorant at two different angles was injected (30° and 45°). We evaluated the relation of the colorant with the main vessels. Results: We found two perforators per quadrant. The thickness of the gluteal muscle was 2.84 ± 1.54 cm. The area under the muscle where the superior gluteal vessels traverse the muscle was located 6.4 ± 1.54 cm from the intergluteal crease and 5.8 ± 1.13 cm from the superior border of the muscle. The inferior gluteal vessels were located 8.3 ± 1.39 cm from the intergluteal crease and 10 ± 2.24 cm from the superior border of the muscle. When we compared the fat injected at a 30° angle, the colorant stayed in the muscle. Using a 45° angle, the colorant was in contact with the superior gluteal artery and the sciatic nerve. No puncture or tear was observed in the vessels or the nerve. Conclusions: The location where the vessels come in contact with the muscle, which can be considered for fat injection, were located in quadrants 1 and 3. A 30° angle allows for an injection into the muscle without passing into deeper structures, unlike a 45° injection angle.

1 January 2016 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
SRSimón Quetzalcoatl Rodríguez-Lara
Simón Quetzalcoatl Rodríguez-Lara
EMErnesto German GERMAN Cardona Muñoz
Ernesto German GERMAN Cardona Muñoz
ERErnesto Javier Ramírez-Lizardo
Ernesto Javier Ramírez-Lizardo
STSylvia Elena Totsuka-Sutto
Sylvia Elena Totsuka-Sutto
ACAraceli Castillo-Romero
Araceli Castillo-Romero
LBLeonel García Benavides
Leonel García Benavides
Ischemia/reperfusion (I/R) lesions are a phenomenon that occurs in multiple pathological states and results in a series of events that end in irreparable damage that severely affects the recovery and health of patients. The principal therapeutic approaches include preconditioning, postconditioning, and remote ischemic preconditioning, which when used separately do not have a great impact on patient mortality or prognosis. Oxidative stress is known to contribute to the damage caused by I/R; however, there are no pharmacological approaches to limit or prevent this. Here, we explain the relationship between I/R and the oxidative stress process and describe some pharmacological options that may target oxidative stress‐states.